Maintenance therapy for early loss of B-cell aplasia after CD19 CAR T-cell therapy.
Gabelli M, Oporto-Espuelas M, Bonney DK, Burridge S, Farish S, Mullanfiroze K, Lazareva A, Samarasinghe S, Ancliff P, Vora A, Bartram J, Hedges E, Ware K, Young L, Williams L, Chu J, Cugno C, Chenchara L, Montibeller Furtado E Silva J, Mirci-Danicar O, Riley L, Pavasovic V, Rao A, Lucchini G, Chiesa R, Rao K, Shenton G, Hodby K, Alajangi R, Jalowiec KA, Hough RE, Amrolia PJ, Ghorashian S.
Gabelli M, et al. Among authors: shenton g.
Blood Adv. 2023 Oct 11:bloodadvances.2023011168. doi: 10.1182/bloodadvances.2023011168. Online ahead of print.
Blood Adv. 2023.
PMID: 37820111
No abstract available.